# OnCo record paper-kras-nsclc-j-clin-oncol-2005 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-kras-nsclc-j-clin-oncol-2005/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-kras-nsclc-j-clin-oncol-2005" ;
  schema:name "Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib"@en ;
  schema:description "Phase 2 or 3 results paper on KRAS in Non-small-cell lung cancer, in Journal of Clinical Oncology (2005), one of the most cited Europe PMC records with KRAS in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-kras-nsclc-j-clin-oncol-2005/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.2005.02.857>, <https://pubmed.ncbi.nlm.nih.gov/16043828/>, <https://europepmc.org/article/MED/16043828> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.2005.02.857> ;
  schema:datePublished "2005"^^xsd:gYear ;
  schema:author "Eberhard DA, Johnson BE, Amler LC, et al." ;
  onco:journals <https://onco.cc/journals/jco/> .